GHRS - GH Research PLC Ordinary Shares

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
13.32 1.18 (8.86%)	---	---	---	-0.28 (-2.1%)	1.2 (9.01%)	0.0 (0.0%)	0.0 (0.0%)

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Category: /stock/categories/na

Market Period: Closed

Earnings & Ratios

Basic EPS:
Diluted EPS:
Basic P/E:
Diluted P/E:
RSI(14) 1m:: 100.0
VWAP:: 14.5
RVol:: 1.631

Events

Period	Kind	Movement	Occurred At
Day	Price increase day	14.66 +1.34 (+10.06%)	Oct 15 15:47
60m	Price increase 60m	14.36 +0.76 (+5.59%)	Oct 15 12:38
10m	Price increase 10m	14.25 +0.47 (+3.41%)	Oct 15 12:37
1m	Price increase 1m	14.09 +0.14 (+1.0%)	Oct 15 12:35
1m	Price decrease 1m	13.64 -0.14 (-1.02%)	Oct 15 12:26